[1]张小刚,武英彪,罗 俊,等.Laager与Watchman左心耳封堵器临床疗效对比[J].介入放射学杂志,2021,30(03):230-234.
　ZHANG Xiaogang,WU Yingbiao,LUO Jun,et al.Laager occluder versus Watchman occluder for left atrial appendage closure： comparison of the clinical efficacy[J].journal interventional radiology,2021,30(03):230-234.
点击复制

Laager与Watchman左心耳封堵器临床疗效对比()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年03
页码:
230-234
栏目:
心脏介入
出版日期:
2021-03-29

文章信息/Info

Title:
Laager occluder versus Watchman occluder for left atrial appendage closure： comparison of the clinical efficacy
作者:
张小刚;  武英彪;  罗 俊;  丛新鹏;  宁忠平
Author(s):
ZHANG Xiaogang;  WU Yingbiao;  LUO Jun;  CONG Xingpeng;  NING Zhongping.
Department of Cardiology， Affiliated Zhoupu Hospital， Shanghai University of Medicine & Health Sciences， Shanghai 201318， China
关键词:
【关键词】 心房颤动;  经皮左心耳封堵术;  Laager封堵器;  Watchman封堵器;  对比;  脑梗死预防
文献标志码:
A
摘要:
【摘要】 目的 对比经皮左心耳封堵术中Laager封堵器与Watchman封堵器围手术期安全性和近期临床疗效。 方法 入选2018年1月至2019年1月在上海市周浦医院接受全身麻醉下经皮左心耳封堵术治疗的76例非瓣膜性心房颤动（房颤）患者，采集患者基线、围手术期、术后45 d、术后12个月经食管超声心动图（TEE）及术后12个月临床事件资料，通过倾向值匹配进行统计学分析。结果 连续76例患者中16例植入Laager封堵器，60例植入Watchman封堵器。1∶1倾向值匹配后，Laager封堵器组、Watchman封堵器组均为16例，年龄分别为（68.5±7.7）岁、（71.1±6.7）岁，房颤血栓危险度评分（CHA2DS2-VASc）分别为4.5±1.3、4.7±1.6，抗凝治疗出血风险评估评分（HAS-BLED）均为3.1±0.7，差异均无统计学意义（P＞0.05）。76患者封堵器植入均获成功。倾向值匹配后Laager封堵器组、Watchman封堵器组患者围手术期并发症发生率均为6.3%（1/16），临床复合终点发生率分别为25.0%（4/16）、18.8%（3/16），差异无统计学意义（P＞0.05），术后12个月患者生存分析无差异。结论 Laager左心耳封堵在器械植入成功率、围手术期安全性、临床有效性方面与Watchman封堵器对比无差异。

参考文献/References:

［1］ Stoddard MF， Dawkins PR， Prince CR， et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event： a transesophageal echocardiographic study［J］. J Am Coll Cardiol， 1995， 25： 452-459.
［2］ Blackshear JL， Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation［J］. Ann Thorac Surg， 1996， 61： 755-759.
［3］ Lip GY， Hammerstingl C， Marin F， et al. Left atrial thrombus resolution in atrial fibrillation or flutter： results of a prospective study with rivaroxaban（X- TRA） and a retrospective observational registry providing baseline data（CLOT-AF）［J］. Am Heart J， 2016， 178： 126-134.
［4］ Cresti A， García-Fernandez MA， Sievert H， et al. Prevalence of extra-appendage thrombosis in non- valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion： a large transoe- sophageal echo study［J］. EuroIntervention， 2019， 15： e225- e230.
［5］ 刘 育，黄 鹤，黄从新． 左心耳封堵预防心房颤动患者脑卒中的研究进展［J］． 中华心律失常学杂志， 2016， 20：389-391．
［6］ Phillips KP， Santoso T， Sanders P， et al. Left atrial appendage closure with WATCHMAN in Asian patients： 2 year outcomes from the WASP registry［J］. Int J Cardiol Heart Vasc， 2019， 23： 100358.
［7］ Brouwer TF， Whang W， Kuroki K， et al. Net clinical benefit of left atrial appendage closure versus warfarin in patients with atrial fibrillation： a pooled analysis of the randomized PROTECT-AF and PREVAIL studies［J］. J Am Heart Assoc， 2019， 8： e013525.
［8］ Kabra R， Girotra S， Vaughan Sarrazin M. Clinical outcomes of mortality， readmissions， and ischemic stroke among Medicare patients undergoing left atrial appendage closure via implanted device［J］. JAMA Netw Open， 2019， 2： e1914268.
［9］ Reddy VY， Doshi SK， Kar S， et al. 5-year outcomes after left atrial appendage closure from the PREVAIL and PROTECT AF trials［J］. J Am Coll Cardiol， 2017， 70： 2964-2975.
［10］ 黄从新，张 澍，黄德嘉，等． 心房颤动：目前的认识和治疗的建议-2018［J］． 中国心脏起搏与心电生理杂志， 2018， 32：315-368．
［11］ 汤学超，白 元，张志钢，等． 左心耳封堵器临床研究进展［J］．介入放射学杂志， 2017， 26：281-284．
［12］ Boersma L， Schmidt B， Betts TR， et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device： peri-procedural outcomes from the EWOLUTION registry［J］. Eur Heart J， 2016， 37： 2465-2474.
［13］ Reddy VY， Gibson DN， Kar S， et al. Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation［J］. J Am Coll Cardiol， 2017， 69：253-261.
［14］ Tzikas A， Shakir S， Gafoor S， et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation： multicentre experience with the AMPLATZER Cardiac Plug［J］. EuroIntervention， 2016， 11： 1170-1179.
［15］ Fauchier L， Cinaud A， Brigadeau F， et al. Device- related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation［J］. J Am Coll Cardiol， 2018， 71： 1528-1536.
［16］ Dukkipati SR， Kar S， Holmes DR， et al. Device- related thrombus after left atrial appendage closure： incidence， predictors， and outcomes［J］. Circulation， 2018， 138： 874-885.
［17］ Han Z， Wu X， Chen Z， et al. Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonval- vular atrial fibrillation：a meta- analysis［J］. BMC Cardiovasc Disord， 2019，19：138.

相似文献/References:

[1]顾佳宁,姜伟峰,周 立,等.瑞舒伐他汀对持续性心房颤动导管消融术后早期复发的影响[J].介入放射学杂志,2014,(10):848.
　GU Jia ning,JIANG Wei feng,ZHOU Li,et al.Evaluation of rosuvastatin in preventing early recurrence of persistent atrial fibrillation after catheter ablation treatment[J].journal interventional radiology,2014,(03):848.
[2]袁 伟,仲建军,李卫东,等.急症经皮冠状动脉血栓抽吸介入治疗心房颤动血栓致急性ST段抬高型心肌梗死11例[J].介入放射学杂志,2019,28(09):870.
　YUAN Wei,ZHONG Jianjun,LI Weidong,et al.Emergency percutaneous coronary interventional thrombus aspiration for acute ST- segment elevation myocardial infarction induced by atrial fibrillation thrombus： clinical effect in 11 patients[J].journal interventional radiology,2019,28(03):870.
[3]金 灿,罗 俊,武英彪,等.心房颤动伴慢性肾脏病患者经皮左心耳封堵术后抗栓治疗方案研究[J].介入放射学杂志,2020,29(12):1187.
　JIN Can,LUO Jun,WU Yingbiao,et al.Antithrombotic therapeutic regimens for atrial fibrillation patients with chronic kidney disease after receiving left atrial appendage closure： a clinical study[J].journal interventional radiology,2020,29(03):1187.
[4]吴美桦,郜俊清.肺静脉隔离术联合肾动脉去交感神经术临床治疗心房颤动meta分析[J].介入放射学杂志,2021,30(01):9.
　WU Meihua,GAO Junqing..Pulmonary vein isolation combined with renal artery denervation for the treatment of atrial fibrillation： a meta analysis[J].journal interventional radiology,2021,30(03):9.
[5]智 宏,孟敬军,靳 浩,等.睡眠质量对心房颤动患者导管消融术后复发的影响[J].介入放射学杂志,2021,30(07):647.
　ZHI Hong,MENG Jingjun,JIN Hao,et al.The influence of sleep quality on the recurrence of atrial fibrillation after catheter ablation[J].journal interventional radiology,2021,30(03):647.
[6]王远龙,刘 飞,沈成兴.经单侧右股静脉射频消融治疗心房颤动可行性研究[J].介入放射学杂志,2021,30(10):985.
　WANG Yuanlong,LIU Fei,SHEN Chengxing..Radiofrequency ablation purely-via right femoral vein approach for the treatment of atrial fibrillation： study of its feasibility[J].journal interventional radiology,2021,30(03):985.
[7]赵志宏,王赛华,罗 俊,等.心房颤动患者左心耳LAmbre封堵术后器械相关血栓发生及转归分析[J].介入放射学杂志,2022,31(02):130.
　ZHAO Zhihong,WANG Saihua,LUO Jun,et al.Device-related thrombosis after LAmbre left atrial appendage occlusion in patients with atrial fibrillation： analysis of its occurrence and outcomes[J].journal interventional radiology,2022,31(03):130.
[8]柳芳美,王 健,邓 敏,等.房间隔缺损封堵术后成功植入LAmbre左心耳封堵器1例[J].介入放射学杂志,2022,31(03):252.
　LIU Fangmei,WANG Jian,DENG Min,et al.Successful implantation of LAmbre device in a patient having received atrial septal defect closure[J].journal interventional radiology,2022,31(03):252.
[9]王赛华,赵志宏,宋 湘,等.LAmbre封堵器封堵左心耳后密封盘周围漏与封堵器相关血栓发生的关系[J].介入放射学杂志,2022,31(05):442.
　WANG Saihua,ZHAO Zhihong,SONG Xiang,et al.The correlation between peridevice leak and device-related thrombus after left atrial appendage closure with LAmbre occluder[J].journal interventional radiology,2022,31(03):442.
[10]王佳旺,肖 夏,曹绪芬.心房颤动致多脏器栓塞1例[J].介入放射学杂志,2022,31(08):841.
　WANG Jiawang,XIAO Xia,CAO Xufen..Multiple-organ embolism caused by atrial fibrillation： report of one case[J].journal interventional radiology,2022,31(03):841.
[11]王子荣,杨 栋,徐 曌,等.左心耳封堵术MSCT三维成像测量可行性分析和临床应用[J].介入放射学杂志,2016,(12):1035.
　WANG Zi- rong,YANG Dong,XU Zhao,et al.MSCT three- dimensional imaging measurement for percutaneous transcatheter left atrial appendage occlusion： feasibility analysis and clinical application[J].journal interventional radiology,2016,(03):1035.

备注/Memo

备注/Memo:
（收稿日期：2020-07-20）
（本文编辑：边 佶）
更新日期/Last Update: 2021-03-24